A pharmacist's reading list

Weighing the Evidence Behind a Fingertip Scan

Pharmacists spend the day weighing claims: a manufacturer's data sheet, a leaflet, an article a customer has printed off. This page applies the same habit to Prysm iO. It sorts what exists into three kinds of source, says who paid for each where that is known, and says what each one can and cannot support. What the scanner returns is a wellness score built on skin carotenoids, taken from a fingertip with light. Nothing below turns that into a statement about anybody's medicines, conditions or treatment.

Three Kinds of Source, Three Different Weights

  • A university review. Written by Yale researchers about earlier-generation scanners, not about Prysm iO.
  • A published comparison with a blood test. Looks at Prysm iO itself, but its funders were the maker, NSE Products, and Brigham Young University.
  • A company-reported bulletin. A Shanghai study of 589 adults, put out by Nu Skin. No independent journal has published or reviewed it.

Where the Scanner Line Began

Pharmanex introduced its first Biophotonic Scanner in 1999, a machine that filled a room and took roughly an hour to calibrate. By 2002 a smaller portable unit existed, based on Raman spectroscopy (the technique is named for the physicist C.V. Raman and is about a century old). Three commercial models followed: the S1 in 2003, the S2 in 2006, and the S3 in 2013, which added Bluetooth and scans of around 30 seconds. Across the line, scanners ended up in 51 countries and recorded more than 25 million scans.

Prysm iO counts as the fourth generation, but it is not an S3 in a new case. Two things differ. The scan is taken at a fingertip instead of the palm, and the technology underneath is patent-pending “spectral ray” sensing, which observes how skin interacts with light through hundreds of thousands of measurements per scan. The same basic idea sits inside a pulse oximeter. Raman spectroscopy instead relies on an emitted signal. The AI-driven scoring in Prysm iO continues to refer to the Raman research base, yet the 30-second timing and the Raman method themselves are S3 traits. The legacy it carries is over 20 years of R&D and data from more than 25 million scans.

The University Foundation

Measuring carotenoids through the skin, as an indicator of how much fruit and vegetables someone eats, has more than ten years of published research behind it. A large share was led by Dr. Susan T. Mayne's group, based at the Yale School of Public Health and Yale Cancer Center, in partnership with the University of Utah physicists who constructed the first instruments.

There was a practical reason for choosing a non-invasive scan. Asking graduate students to collect blood from children, in a study of what inner-city kids ate, was something the team preferred to avoid, and a scan solved it. The motivation was fieldwork logistics rather than marketing.

Their 2013 review, in Archives of Biochemistry and Biophysics, drew on studies they had run themselves (a 1,375-adult survey and a 381-child study among them) as well as other published work. It described the method in this sentence:

“Skin carotenoid status as assessed by RRS is an attractive biomarker for use in human studies.”

- Mayne ST, Cartmel B, Scarmo S, Jahns L, Ermakov IV, Gellermann W. “Resonance Raman spectroscopic evaluation of skin carotenoids as a biomarker of carotenoid status for human studies.” Arch Biochem Biophys. 2013;539(2):163-70. PubMed

Be clear about scope. What the review examined was earlier-generation resonance Raman spectroscopy (RRS) devices. Prysm iO was not the subject, and the review makes no direct statement about it.

The authors also observed that when people record their own diet, it is hard to know whether behaviour has really altered, and that is part of what drew researchers to skin carotenoids. Their view was that the skin reading can serve as a biomarker of fruit and vegetable intake, rising and falling with supplementation and dietary change. They were frank, too, that diet explains just a portion of the variation observed and that bigger studies were needed. Later scanners, Prysm iO included, sit on this foundation.

One Number, Read Carefully

A specialised blood test exists for serum carotenoids. Routine bloodwork does not include it, and a typical turnaround from a specialist lab is about three weeks, yet it is a recognised way of measuring this biomarker. With the dermatologist Dr. Zoe Draelos involved, Nu Skin funded a study placing Prysm iO's 15-second skin reading beside that blood test across 97 participants.

R² = 0.77

How closely Prysm iO scores tracked serum carotenoids in the blood, in a Nu Skin-funded study of 97 people.

Riggs M, Knaggs H, Lephart ED, Gibb T, Draelos ZD. Food & Nutrition Journal, 2026 (the paper reports R² = 0.7659 for Prysm iO). Read the paper. The study was funded by NSE Products (the maker of Prysm iO) and Brigham Young University.

Every measuring device has a margin of error, and Nu Skin quotes about ±10% for typical field use. One reading is a snapshot. Repeated scans over time, and the direction they move in, tell you more.

The Shanghai Bulletin

A further study, reported by Nu Skin, was carried out at Shanghai Jiao Tong University. Researchers scanned 589 healthy adults and compared the scores with what people said about their diet, lifestyle, fitness and sleep. People who scored higher tended to eat more fruit, vegetables, whole grains and freshwater fish, had a balanced BMI, put sleep first, exercised regularly and limited UV exposure. People who scored lower tended to eat more fried food, sugary drinks and red meat.

Keep this in proportion. Nu Skin is the source, the findings are correlational, and the diet and outcome information was self-reported. No independent journal has published and peer-reviewed it. It is helpful supporting material, but it is not equal in weight to the Yale review.

Source: Nu Skin research bulletin on Prysm iO (NSE Products, 2026), principal investigator Professor Cai of Jiao Tong University. Read the bulletin (PDF). The bulletin also gives a correlation of 0.806, across those same 589 people, between Prysm iO and BioPhotonic Scanner S3 scores.

If a Customer Brings You the Number

Someone who has had a scan may carry the number to the counter and ask what to do about it. That is a fair question, and the answer sits inside your own training. What it gives is a wellness score based on skin carotenoids, and that says nothing about the medicines a person takes, the conditions they live with, or whether a given product would suit them. You know those things, or know how to ask about them, and a fingertip scan cannot stand in for that.

What the evidence above supports is narrower. Skin carotenoid readings have been studied in research as a way to follow fruit and vegetable intake, one comparison with a blood test has been published (paid for by the maker), and a single reading carries a margin of around 10 percent. A sensible reply is therefore to treat one number as a snapshot, talk about food and everyday habits in general terms, and watch how the score moves across repeated scans.

If the conversation drifts towards symptoms, medicines or treatment, it belongs in your normal consultation, under your own regulator's standards, and not in a discussion of a score.

The Money-Back Policy, in Plain Terms

“Prysm Certified” is a label Nu Skin applies to some products, and it runs a money-back policy covering certified, Prysm-eligible items, governed by Nu Skin's Terms and Conditions. Should a customer raise it, direct them to those terms rather than summarising from memory. This is a consumer policy. It does not promise that anybody's score will move.

Outside Recognition

Separately from Nu Skin's own research, Prysm iO has received these awards since launch:

  • Achievement in Technology Innovation - TITAN Business Awards (winner page)
  • Best of Category, Wellness Insight - Globee Business Awards
  • Personal category winner - Good Design Awards 2025 (project page)

Prysm iO is a wellness insight tool. It is not a medical device and is not intended to diagnose, treat, cure, prevent, or mitigate any disease or medical condition. It is not a substitute for pharmacist advice, medical assessment or dietetic advice.